VEGF receptor binding peptide-linked amphiphilic peptide with arginines and valines for endothelial cell-specific gene delivery

Journal of Drug Targeting

Volumn 20, Issue 7, 2012, Pages 574-581

  Ryu, Dong Wook ^a   Kim, Hyun Ah ^a   Kim, Soonhag ^b   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

^b CHA University   (South Korea)

Author keywords

Amphiphilic peptide; Endothelial cells; Gene delivery; Targeting; Transfection

Indexed keywords

3 ARGININE 6 VALINE; ARGININE; BINDING PROTEIN; DEOXYRIBONUCLEASE I; DNA; HEPARIN; UNCLASSIFIED DRUG; VALINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL HYPOXIA; CYTOTOXICITY; ENDOTHELIUM CELL; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; RECEPTOR BINDING;

ARGININE; CELL SURVIVAL; CELLS, CULTURED; DEOXYRIBONUCLEASE I; DNA; ENDOTHELIAL CELLS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEPARIN; HUMANS; PEPTIDES; TRANSFECTION; VALINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84863451182     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.697166     Document Type: Article

References (32)

1. Barry ME, Pinto-González D, Orson FM, McKenzie GJ, Petry GR, Barry MA. (1999). Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after nakedDNA injection. Hum Gene Ther, 10, 2461-2480.
2. Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC. (2000). Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J, 19, 1525-1533.
3. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest, 97, 469-476.
4. Chavand O, Spilsbury K, Rakoczy PE. (2001). Addition of a c-myc epitope tag within the VEGF protein does not affect in vitro biological activity. Biochem Cell Biol, 79, 107-112.
5. Choi YH, Liu F, Kim JS, Choi YK, Park JS, Kim SW. (1998). Polyethyleneglycol-grafted poly-L-lysine as polymeric gene carrier. J Control Release, 54, 39-48.
6. Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ. (1997). Targeting gene therapy to cancer: a review. Oncol Res, 9, 313-325.
7. El-Mousawi M, Tchistiakova L, Yurchenko L, Pietrzynski G, Moreno M, Stanimirovic D, Ahmad D, Alakhov V. (2003). A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J Biol Chem, 278, 46681-46691.
8. Godbey WT, Wu KK, Mikos AG. (1999). Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res, 45, 268-275.
9. Han JS, Kim HA, Lee S, Lee M. (2010). VEGF receptor binding peptidelinked high mobility box group-1 box A as a targeting gene carrierfor hypoxic endothelial cells. J Cell Biochem, 110, 1094-1100.
10. Han JS, Kim K, Lee M. (2009). A high mobility group B-1 box A peptidecombined with an artery wall binding peptide targets delivery ofnucleic acids to smooth muscle cells. J Cell Biochem, 107, 163-170.
11. Han S, Mahato RI, Kim SW. (2001). Water-soluble lipopolymer for gene delivery. Bioconjug Chem, 12, 337-345.
12. Han S, Mahato RI, Sung YK, Kim SW. (2000). Development ofbiomaterials for gene therapy. Mol Ther, 2, 302-317.
13. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R,Cheresh DA. (2002). Tumor regression by targeted gene delivery tothe neovasculature. Science, 296, 2404-2407.
14. Kang HC, Lee M, Bae YH. (2005). Polymeric gene carriers. Crit RevEukaryot Gene Expr, 15, 317-342.
15. Kawakami S, Higuchi Y, Hashida M. (2008). Nonviral approaches fortargeted delivery of plasmid DNA and oligonucleotide. J PharmSci, 97, 726-745.
16. Kim K, Han JS, Kim HA, Lee M. (2008). Expression, purification and characterization of TAT-high mobility group box-1A peptide as
17. Kim WJ, Yockman JW, Lee M, Jeong JH, Kim YH, Kim SW. (2005a). Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. J Control Release, 106, 224-234.
18. Kim YH, Park JH, Lee M, Kim YH, Park TG, Kim SW. (2005b). Polyethylenimine with acid-labile linkages as a biodegradablegene carrier. J Control Release, 103, 209-219.
19. Kircheis R, Wightman L, Schreiber A, Robitza B, Rössler V, Kursa M, Wagner E. (2001). Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther, 8, 28-40.
20. Kunath K, Merdan T, Hegener O, Häberlein H, Kissel T. (2003a). Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. JGene Med, 5, 588-599.
21. Kunath K, von Harpe A, Fischer D, Petersen H, Bickel U, Voigt K, KisselT. (2003b). Low-molecular-weight polyethylenimine as a nonviralvector for DNA delivery: comparison of physicochemicalproperties, transfection efficiency and in vivo distribution withhigh-molecular-weight polyethylenimine. J Control Release, 89, 113-125.
22. Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW. (2001). Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res, 18, 427-431.
23. Lemkine GF, Goula D, Becker N, Paleari L, Levi G, Demeneix BA. (1999). Optimisation of polyethylenimine-based gene delivery to mouse brain. J Drug Target, 7, 305-312.
24. McKee TD, DeRome ME, Wu GY, Findeis MA. (1994). Preparation of asialoorosomucoid-polylysine conjugates. Bioconjug Chem, 5, 306-311.
25. Niidome T, Huang L. (2002). Gene therapy progress and prospects: nonviral vectors. Gene Ther, 9, 1647-1652.
26. Ryu DW, Kim HA, Song H, Kim S, Lee M. (2011). Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA. J Cell Biochem, 112, 1458-1466.
27. Suh W, Han SO, Yu L, Kim SW. (2002). An angiogenic, endothelial- celltargeted polymeric gene carrier. Mol Ther, 6, 664-672.
28. Turunen MP, Hiltunen MO, Ruponen M, Virkamäki L, Szoka FC Jr, Urtti A, Ylä-Herttuala S. (1999). Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther, 6, 6-11.
29. Wang S, Low PS. (1998). Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release, 53, 39-48.
30. Wightman L, Patzelt E, Wagner E, Kircheis R. (1999). Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells. J Drug Target, 7, 293-303.
31. Wu GY, Wu CH. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem, 262, 4429-4432.
32. Wu GY, Wu CH. (1988). Receptor-mediated gene delivery and expression in vivo. J Biol Chem, 263, 14621-14624.